Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1

被引:674
|
作者
Opferman, JT [1 ]
Letai, A [1 ]
Beard, C [1 ]
Sorcinelli, MD [1 ]
Ong, CC [1 ]
Korsmeyer, SJ [1 ]
机构
[1] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA
关键词
D O I
10.1038/nature02067
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Regulated apoptosis is essential for both the development and the subsequent maintenance of the immune system(1,2). Interleukins, including IL- 2, IL- 4, IL- 7 and IL- 15, heavily influence lymphocyte survival during the vulnerable stages of VDJ rearrangement and later in ensuring cellular homeostasis, but the genes specifically responsible for the development and maintenance of lymphocytes have not been identified(3 - 8). The antiapoptotic protein MCL- 1 is an attractive candidate, as it is highly regulated(9), appears to enhance short- term survival(10) and functions at an apical step in genotoxic deaths(11). However, Mcl- 1 deficiency results in peri- implantation lethality(12). Here we show that mice conditional for Mcl- 1 display a profound reduction in B and T lymphocytes when MCL- 1 is removed. Deletion of Mcl- 1 during early lymphocyte differentiation increased apoptosis and arrested the development at pro- B- cell and double- negative T- cell stages. Induced deletion of Mcl- 1 in peripheral B- and T- cell populations resulted in their rapid loss. Moreover, IL- 7 both induced and required MCL- 1 to mediate lymphocyte survival. Thus, MCL- 1, which selectively inhibits the proapoptotic protein BIM, is essential both early in lymphoid development and later on in the maintenance of mature lymphocytes.
引用
收藏
页码:671 / 676
页数:6
相关论文
共 50 条
  • [21] Cytokine-dependent and cytokine-independent roles for Mcl-1: genetic evidence for multiple mechanisms by which Mcl-1 promotes survival in primary T lymphocytes
    A Dunkle
    I Dzhagalov
    Y-W He
    Cell Death & Disease, 2011, 2 : e214 - e214
  • [22] Cytokine-dependent and cytokine-independent roles for Mcl-1: genetic evidence for multiple mechanisms by which Mcl-1 promotes survival in primary T lymphocytes
    Dunkle, A.
    Dzhagalov, I.
    He, Y-W
    CELL DEATH & DISEASE, 2011, 2 : e214 - e214
  • [23] Development of selective MCL-1 heterobifunctional degraders
    Tomczyk, T.
    Arencibia, J. M.
    Milewicz, M.
    Trebicka, D.
    Skalska, J.
    Poniatowska, K.
    Adamczyk, J.
    Wojcik, K.
    Cottens, S.
    Kowalczyk, P.
    Dobrzanski, P.
    Bista, M.
    Brach, K.
    Switalska-Drewniak, M.
    Tracz, A.
    Pastok, M.
    Gorecka-Minakowska, K.
    Chrzanowska, K.
    Takagi, T.
    Walczak, M.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S104 - S104
  • [24] Development of Mcl-1 inhibitors for cancer therapy
    Negi, Arvind
    Murphy, Paul, V
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 210
  • [25] Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma
    Michels, J
    Foria, V
    Mead, B
    Jackson, G
    Mullee, M
    Johnson, PWM
    Packham, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (06) : 743 - 746
  • [26] Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells
    Wim Pierson
    Bénédicte Cauwe
    Antonia Policheni
    Susan M Schlenner
    Dean Franckaert
    Julien Berges
    Stephanie Humblet-Baron
    Susann Schönefeldt
    Marco J Herold
    David Hildeman
    Andreas Strasser
    Philippe Bouillet
    Li-Fan Lu
    Patrick Matthys
    Antonio A Freitas
    Rita J Luther
    Casey T Weaver
    James Dooley
    Daniel H D Gray
    Adrian Liston
    Nature Immunology, 2013, 14 : 959 - 965
  • [27] Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells
    Pierson, Wim
    Cauwe, Benedicte
    Policheni, Antonia
    Schlenner, Susan M.
    Franckaert, Dean
    Berges, Julien
    Humblet-Baron, Stephanie
    Schonefeldt, Susann
    Herold, Marco J.
    Hildeman, David
    Strasser, Andreas
    Bouillet, Philippe
    Lu, Li-Fan
    Matthys, Patrick
    Freitas, Antonio A.
    Luther, Rita J.
    Weaver, Casey T.
    Dooley, James
    Gray, Daniel H. D.
    Liston, Adrian
    NATURE IMMUNOLOGY, 2013, 14 (09) : 959 - +
  • [28] IEX-1-induced cell death requires BIM and is modulated by MCL-1
    Yoon, Seongmin
    Ha, Hye-Jung
    Kim, Yong-Hak
    Won, Miae
    Park, Mira
    Ko, Jeong-Jae
    Lee, Kangseok
    Bae, Jeehyeon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 382 (02) : 400 - 404
  • [29] Survival control of malignant lymphocytes by anti-apoptotic MCL-1
    Fernandez-Marrero, Y.
    Spinner, S.
    Kaufmann, T.
    Jost, P. J.
    LEUKEMIA, 2016, 30 (11) : 2152 - 2159
  • [30] Survival control of malignant lymphocytes by anti-apoptotic MCL-1
    Y Fernández-Marrero
    S Spinner
    T Kaufmann
    P J Jost
    Leukemia, 2016, 30 : 2152 - 2159